AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EMINENCE MINERALS LTD

0.045

-0.005-10.00%

Volume:47.72K

Turnover:2.14K

Market Cap:7.00M

PE:-1.83

High:0.050

Open:0.050

Low:0.044

Close:0.050

52wk High:0.120

52wk Low:0.044

Shares:155.63M

Float Shares:82.24M

Volume Ratio:0.81

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.025

EPS(LYR):-0.025

ROE:-16.77%

ROA:-9.84%

PB:0.37

PE(LYR):-1.83

Loading ...

Overview Company News Filings

Shiba Inu Open Interest Down 5% Despite SHIB Price Relief Rally

Shiba Inu (SHIB) Unable to Break 26 EMA as Key Breakthrough Attempt Fails

DOGE chart targets $0.06 with weak volume, MAs still bearish

Emera Q4 Adjusted Earnings Fall

MT Newswires Live

Earnings Flash (EMA) Emera Posts Q4 Adjusted EPS CA$0.55, vs. FactSet Est of CA$0.57

MT Newswires Live

Neuren's Regulatory Hurdles for Trofinetide May Push Back EU Royalties, Says Jefferies

MT Newswires Live

Dogecoin Death Cross Countdown: Why This Chart Pattern Is Red Flag for DOGE Price

Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy

BRIEF-Eminence Minerals Appoints Chief Executive Officer

Eminence Minerals Ltd - Appoints Anthony Hills as CEO

THOMSON REUTERS

Emera Faces Few Catalysts, Canadian Growth Headwinds, BofA Securities Says

MT Newswires Live

Polygon price rallies as network pivots to payments with Open Money Stack

Shiba Inu (SHIB) Zero Suddenly Removed After 56 Days of Pain, But There's a Problem

What next for the Pi Network price ahead of the 134M unlock in January?

Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U.S. FDA Approval of LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten

ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed

Eminence Minerals Ltd-Hamersley Iron Ore Project Update

THOMSON REUTERS

Cardano price shows early bullish signs but faces heavy resistance walls

XRP price eyes breakout beyond $2.2 as EMAs and MACD turn bullish

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EMA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMA.AU\",,,,,undefined,":{"symbol":"EMA.AU","market":"AU","secType":"STK","nameCN":"EMINENCE MINERALS LTD","latestPrice":0.045,"timestamp":1772157322226,"preClose":0.05,"halted":0,"volume":47717,"delay":0,"changeRate":-0.10000000000000009,"nameEN":"EMINENCE MINERALS LTD","floatShares":82243410,"shares":155628951,"eps":-0.0246,"marketStatus":"Trading","change":-0.005,"latestTime":"02-27 13:06:14 AEDT","open":0.05,"high":0.05,"low":0.044,"amount":2139,"amplitude":0.12,"askPrice":0.059,"askSize":118672,"bidPrice":0.045,"bidSize":146942,"shortable":3,"etf":0,"ttmEps":-0.0246,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772168400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.05,"openAndCloseTimeList":[[1772146800000,1772168400000]],"volumeRatio":0.809074,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EMA.AU\",,,,,undefined,":{"symbol":"EMA.AU","floatShares":82243410,"roa":"-9.84%","roe":"-16.77%","lyrEps":-0.0246,"volumeRatio":0.809074,"shares":155628951,"dividePrice":0,"high":0.05,"amplitude":0.12,"preClose":0.05,"low":0.044,"week52Low":0.044,"pbRate":"0.37","psRate":"153.75","week52High":0.12,"institutionHeld":0,"latestPrice":0.045,"committee":0.106433,"eps":-0.0246,"divideRate":0,"volume":47717,"delay":0,"ttmEps":-0.0246,"open":0.05,"prevYearClose":0.066,"prevWeekClose":0.054,"prevMonthClose":0.06,"prevQuarterClose":0.066,"fiveDayClose":0.054,"twentyDayClose":0.06,"sixtyDayClose":0.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614902431","title":"Shiba Inu Open Interest Down 5% Despite SHIB Price Relief Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2614902431","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614902431?lang=en_us&edition=fundamental","pubTime":"2026-02-26 14:41","pubTimestamp":1772088060,"startTime":"0","endTime":"0","summary":"Shiba Inu (SHIB) has shown an unusual pattern in the last 24 hours as the meme coin’s open interest keeps dropping despite a price uptick. As perCoinGlass data, Shiba Inu’s open interest has slipped b","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/shiba-inu-open-interest-down-5-despite-shib-price-relief-rally","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/shiba-inu-open-interest-down-5-despite-shib-price-relief-rally","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BK4081","EMA","BK7129","EMA.AU"],"gpt_icon":0},{"id":"2614557049","title":"Shiba Inu (SHIB) Unable to Break 26 EMA as Key Breakthrough Attempt Fails","url":"https://stock-news.laohu8.com/highlight/detail?id=2614557049","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614557049?lang=en_us&edition=fundamental","pubTime":"2026-02-26 11:58","pubTimestamp":1772078280,"startTime":"0","endTime":"0","summary":"Shiba Inu is once again confronted with the 26-day exponential moving average (EMA), a technical barrier that has frequently characterized its price action over the previous few months.With lower high","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/shiba-inu-shib-unable-to-break-26-ema-as-key-breakthrough-attempt-fails","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/shiba-inu-shib-unable-to-break-26-ema-as-key-breakthrough-attempt-fails","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["EMA","BK7129","BK4081","EMA.AU"],"gpt_icon":0},{"id":"2613715134","title":"DOGE chart targets $0.06 with weak volume, MAs still bearish","url":"https://stock-news.laohu8.com/highlight/detail?id=2613715134","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613715134?lang=en_us&edition=fundamental","pubTime":"2026-02-24 19:57","pubTimestamp":1771934259,"startTime":"0","endTime":"0","summary":"DOGE has slid below key weekly MAs, risking a drop toward $0.06 on weak volume and downside Bollinger pressure.DOGE trades below weekly 8 EMA, 34 EMA, 50 SMA and 200 SMA, keeping structure bearish until reclaimed.Price sits near the lower Bollinger Band with low volume, reinforcing downside risk toward the analyst’s $0.06 target.DOGE recently broke below the Oct. 10 crash low; next support aligns with the August 2024 bottom near prior weekly demand.A cryptocurrency analyst has warned that Dogecoin  could decline to $0.06, citing technical indicators that suggest continued downside pressure, according to a chart analysis posted on social media.Bollinger Bands displayed on the same chart place the asset closer to the lower band than the midline, consistent with downside pressure on the weekly timeframe, according to the analysis. The analyst’s $0.06 target would represent a move below the displayed lower Bollinger Band, framing the projection as a deeper continuation scenario.The chart i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/doge-chart-targets-0-06-with-weak-volume-mas-still-bearish/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/doge-chart-targets-0-06-with-weak-volume-mas-still-bearish/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["BK7129","EMA","EMA.AU","BK4217","BK4081","SMA"],"gpt_icon":0},{"id":"2613786772","title":"Emera Q4 Adjusted Earnings Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2613786772","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613786772?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:29","pubTimestamp":1771846154,"startTime":"0","endTime":"0","summary":"Emera (EMA) reported Q4 adjusted earnings Monday of 0.55 Canadian dollar ($0.40) per diluted share, down from CA$0.84 a year earlier.Analysts polled by FactSet expected CA$0.57.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMA","EMA.AU","BK7129","BK4081"],"gpt_icon":0},{"id":"2613863057","title":"Earnings Flash (EMA) Emera Posts Q4 Adjusted EPS CA$0.55, vs. FactSet Est of CA$0.57","url":"https://stock-news.laohu8.com/highlight/detail?id=2613863057","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613863057?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:02","pubTimestamp":1771844559,"startTime":"0","endTime":"0","summary":"Earnings Flash (EMA) Emera Posts Q4 Adjusted EPS CA$0.55, vs. FactSet Est of CA$0.57","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMA","EMA.AU","CA"],"gpt_icon":0},{"id":"2609384536","title":"Neuren's Regulatory Hurdles for Trofinetide May Push Back EU Royalties, Says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2609384536","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609384536?lang=en_us&edition=fundamental","pubTime":"2026-02-06 08:13","pubTimestamp":1770336816,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  facing regulatory uncertainty in the European Union  for its investigational drug trofinetide to treat Rett syndrome may delay royalties from sales in the region, Jefferies said in a note on Thursday.The European Medicines Agency  Committee for Medicinal Products for Human Use  gave a negative trend vote this week on the drug candidate's market authorization application, possibly due to concerns about the effect size in the confirmatory trial.Jefferies said the negative trend vote is an early indication that the regulatory authority might issue a negative opinion on the application at the final vote.The investment firm now expects royalties from EU sales of trofinetide to kick in the fourth quarter of fiscal 2026, and not second quarter.Meanwhile, it projects Neuren's experimental drug NNZ-2591 for treating Pitt-Hopkins Syndrome, a rare neurodevelopmental disorder, will receive reimbursement approval in the US in fiscal 2029.Jefferies lowered the company's fisca","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7129","CHMP","EMA.AU","NEU.AU","BK4156","BK4081","BK7508","EMA","BK4087","BK7096"],"gpt_icon":0},{"id":"2608567193","title":"Dogecoin Death Cross Countdown: Why This Chart Pattern Is Red Flag for DOGE Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2608567193","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608567193?lang=en_us&edition=fundamental","pubTime":"2026-02-03 14:18","pubTimestamp":1770099480,"startTime":"0","endTime":"0","summary":"Dogecoin's slow decline might be heading into technical trouble. As of this week,DOGE is trading at just over $0.107 - barely holding above the Oct. 10 dump level of $0.0995, when $40 billion at least","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/dogecoin-death-cross-countdown-why-this-chart-pattern-is-red-flag-for-doge-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/dogecoin-death-cross-countdown-why-this-chart-pattern-is-red-flag-for-doge-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["IE00BFMHRM44.USD","DOGE.USD.HKCC","LU2048586759.USD","EMA","LU1064131342.USD","BK4217","SMA","LU2211815571.USD","BK7129","BK4081","IE0031619046.USD","BK4161","LU2355687059.USD","IE00B66KJ199.SGD","LU2264538146.SGD","IE00B7SZL793.SGD","EMA.AU","LU1988902786.USD","GTLS","LU0823414478.USD","LU2249611893.SGD","PEGI","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2605144430","title":"Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2605144430","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605144430?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:00","pubTimestamp":1768946400,"startTime":"0","endTime":"0","summary":"Japan's Ministry of Health, Labour and Welfare  grants MCO-010 Sakigake  and Orphan Drug designations, enabling an accelerated regulatory pathway for patients with severe inherited retinal diseases. Enhances strong global regulatory momentum, including multiple FDA expedited programs and five EMA Orphan designations. FDA, EMA and PMDA conditionally approve the MOGENRY brand name. Strengthens global pre-commercialization readiness and reinforces leadership in optogenetic therapy. DALLAS, Jan. 21, 2026 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a biotechnology company developing disease-agnostic therapies for vision loss caused by retinal degeneration, today announced that Japan's Ministry of Health, Labour and Welfare  has granted both Sakigake  and Orphan Drug designations to MCO-010, its lead optogenetic therapy for patients with severe vision loss from inherited retinal dystrophies . Approximately 50,000 patients in Japan are affected by IRDs.The MHLW decision builds on strong reg","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2718911/NSCOPE_nu_Horizontal_2Color_1200px_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2718911/NSCOPE_nu_Horizontal_2Color_1200px_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/nanoscope-secures-japan-mhlw-sakigake-and-orphan-drug-designations-across-inherited-retinal-diseases--a-first-for-a-retinal-gene-therapy-302665003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLA.AU","BK7129","EMA","BK4081","EMA.AU"],"gpt_icon":0},{"id":"2604901274","title":"BRIEF-Eminence Minerals Appoints Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604901274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604901274?lang=en_us&edition=fundamental","pubTime":"2026-01-19 11:33","pubTimestamp":1768793631,"startTime":"0","endTime":"0","summary":"BRIEF-Eminence Minerals Appoints Chief Executive OfficerJan 19 (Reuters) - Eminence Minerals Ltd EMA.AX:EMINENCE APPOINTS CHIEF EXECUTIVE OFFICERAPPOINTS ANTHONY HILLS AS CEOFurther company coverage: EMA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nTUE924ZBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA.AU","BK7129"],"gpt_icon":0},{"id":"2604997272","title":"Eminence Minerals Ltd - Appoints Anthony Hills as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2604997272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604997272?lang=en_us&edition=fundamental","pubTime":"2026-01-19 05:23","pubTimestamp":1768771415,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260118:nTUE924ZBT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7129","EMA.AU"],"gpt_icon":0},{"id":"2603754219","title":"Emera Faces Few Catalysts, Canadian Growth Headwinds, BofA Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2603754219","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603754219?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:49","pubTimestamp":1768236597,"startTime":"0","endTime":"0","summary":"Emera's  updated capital plan and reaffirmed earnings guidance offer clarity on near-term growth, but these have already been priced in, leaving limited room for upside, BofA Securities said in a note Monday.The updated capital plan reflects slower Canadian growth and focuses on Florida, the brokerage said, adding that it agrees with the management's plan to prioritize Florida operations.However, BofA said it is hard to rationalize a premium on just Florida's outlook, particularly due to the lack of significant catalysts like data center-driven load growth that utilities in the Southeast are benefiting from.The brokerage also said Nova Scotia's economic challenges and questions around its regulatory environment dampen confidence in consolidated growth, making it difficult to forecast upside beyond the 5% to 7% earnings per share growth guidance range, which is below the 8% consensus estimate.BofA downgraded Emera to neutral from buy, and lowered its price target to 69 Canadian dollars ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMA.AU","BK7129","BK4081","EMA"],"gpt_icon":0},{"id":"2602392008","title":"Polygon price rallies as network pivots to payments with Open Money Stack","url":"https://stock-news.laohu8.com/highlight/detail?id=2602392008","media":"cryptonews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602392008?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:51","pubTimestamp":1767898303,"startTime":"0","endTime":"0","summary":"Polygon’s native token extended its rally for an eighth straight session, climbing to its highest level since Dec. 2 as network activity surged, alongside the company’s unveiling of the Open Money Stack — a modular, chain-neutral payments infrastructure aimed at enabling regulated, interoperable stablecoin payments and modernizing global money movement.As part of the shift, Polygon is formally positioning itself as a payments company, with a rebrand expected in the coming weeks to reflect a fintech- and institution-focused strategy that remains compatible with existing financial rails and regulatory frameworks.Polygon token price rose for eight consecutive days.The token has jumped by over 20% from its lowest point this year.The Supertrend indicator has turned positive for the first time since August.Polygon , a top layer-2 network, jumped to $0.1300, up by over 20% from its lowest level this year. This rebound continued even as other top cryptocurrencies continued falling.Polygon has ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/polygon-price-rallies-open-money-stack/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/polygon-price-rallies-open-money-stack/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["BK7129","BK7104","POL.AU","POL.USD.HKCC","EMA","EMA.AU","BK4081"],"gpt_icon":0},{"id":"2601489192","title":"Shiba Inu (SHIB) Zero Suddenly Removed After 56 Days of Pain, But There's a Problem","url":"https://stock-news.laohu8.com/highlight/detail?id=2601489192","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601489192?lang=en_us&edition=fundamental","pubTime":"2026-01-06 08:32","pubTimestamp":1767659520,"startTime":"0","endTime":"0","summary":"For a brief period, Shiba Inu provided what many investors had been anticipating: the elimination of yet another zero from its price. SHIB surged to the $0.00001 level during a strong intraday move, t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/shiba-inu-shib-zero-suddenly-removed-after-56-days-of-pain-but-theres-a-problem","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/shiba-inu-shib-zero-suddenly-removed-after-56-days-of-pain-but-theres-a-problem","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["EMA","EMA.AU","BK7129","BK4081"],"gpt_icon":0},{"id":"2595737553","title":"What next for the Pi Network price ahead of the 134M unlock in January?","url":"https://stock-news.laohu8.com/highlight/detail?id=2595737553","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595737553?lang=en_us&edition=fundamental","pubTime":"2025-12-30 02:41","pubTimestamp":1767033665,"startTime":"0","endTime":"0","summary":"The Pi Network price has moved sideways over the past six days as demand waned and traders waited for another large token unlock in the new year.Pi Coin  token was stuck at $0.2025, down by more than 93% from its all-time high. Its liquidity has largely dried, with trading volume falling to $10 million, a small amount for a cryptocurrency valued at over $1.6 billion.Meanwhile, Pi Network’s team is working on several initiatives to boost its price over time. It has already invested in two companies — CiDi Games and OpenMind — using part of the $100 million ecosystem fund launched in May this year.Additionally, they are currently running a trial of their decentralized exchange and automated market maker tools, with the mainnet scheduled to launch in 2026. The goal of this platform is to provide greater utility to the Pi token and potentially increase its price over time.Bitcoin price hits $90k wall—and the floor may be $80k","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/what-next-for-the-pi-network-price-ahead-jan-unlock/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/what-next-for-the-pi-network-price-ahead-jan-unlock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["PI","EMA.AU","BK4141","LU1878469433.USD","BK4081","BK7129","EMA"],"gpt_icon":0},{"id":"2592967216","title":"Everest Medicines Announces that Licensing Partner LIB Therapeutics has Received U.S. FDA Approval of LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol","url":"https://stock-news.laohu8.com/highlight/detail?id=2592967216","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592967216?lang=en_us&edition=fundamental","pubTime":"2025-12-17 16:10","pubTimestamp":1765959000,"startTime":"0","endTime":"0","summary":"LEROCHOL is a novel, third-generation PCSK9 inhibitor designed to help patients achieve and maintain their LDL-C targets. It is self-administered as a once-monthly, single small-volume subcutaneous injection with extended room-temperature stability , giving patients the freedom to administer it where and when they choose. These features make LEROCHOL a unique alternative to other PCSK9 inhibitors.The FDA approval of LEROCHOL was based on data from the comprehensive global Phase 3 LIBerate Clinical Trial Program, which enrolled a diverse population of over 2,900 patients with cardiovascular disease , or without but at very high or high risk for CVD, including HeFH.In clinical trials, LEROCHOL demonstrated sustained LDL-C reductions of ≥60% in patients with, or at very-high or high risk of CVD and 59% in those with HeFH who have more severe LDL-C elevations. LEROCHOL was generally well tolerated across the LIBerate Clinical Trial Program. Lerodalcibep is expected to expand treatment opti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/everest-medicines-announces-that-licensing-partner-lib-therapeutics-has-received-us-fda-approval-of-lerochol-lerodalcibep-liga-for-adults-with-elevated-ldl-cholesterol-302644459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK7129","BK4007","LDL","BK4139","EMA","EMA.AU","BLA.AU","LENZ","MDCO","BK4539"],"gpt_icon":0},{"id":"2590510262","title":"Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten","url":"https://stock-news.laohu8.com/highlight/detail?id=2590510262","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590510262?lang=en_us&edition=fundamental","pubTime":"2025-12-11 23:57","pubTimestamp":1765468620,"startTime":"0","endTime":"0","summary":"- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveraging Everest's existing commercial organization- Exclusive Greater China license to develop and commercialize Lerodalcibep, a novel, small protein-binding, third-generation PCSK9 inhibitor that adds to the Company's late-stage product pipeline- Together, these agreements drive financial and strategic synergies, improve utilization and productivity of our existing commercial platform, and strengthen commercial capabilities and life-cycle management, while establishing an attractive vertical in cardiovascular disease. SHANGHAI, Dec. 11, 2025 /PRNewswire/ -- Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that its wholly-owned subsidiary, Everest Medicines  Co., Ltd , has entered into two strategic agreements with privatel","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/everest-medicines-announces-commercialization-service-agreement-and-license-agreement-with-hasten-302639416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK7129","MDCO","BLA.AU","EMA.AU","EMA"],"gpt_icon":0},{"id":"2589060328","title":"ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2589060328","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589060328?lang=en_us&edition=fundamental","pubTime":"2025-12-08 06:08","pubTimestamp":1765145280,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ --Telix Pharmaceuticals Limited  today announces that the first patienthas been dosed in Part 2  of its ProstACT Global Phase 3 study evaluating its lead prostate cancer therapy candidate TLX591  in patients with metastatic castration resistant prostate cancer . The patient was dosed at the Australian Prostate Centre  in Melbourne, Australia.ProstACT Global is the first Phase 3 trial to combine aPSMA[1]-targeted radio antibody-drug conjugate  therapy administered together with Standard of Care  versus SOC alone. Part 2 of ProstACT Global will enroll approximately 490 patients and is currently recruiting patients in Australia, New Zealand and Canada.As previously agreed with FDA and disclosed to the market, Telix will submit Part 1 data to the United States  Food and Drug Administration  to enable clearance to expand Part 2 of the trial to U.S. sites. A public disclosure of preliminary results from Part 1 of the study will","market":"hk","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/prostact-global-phase-3-update-first-patient-dosed-in-randomized-treatment-expansion-part-1-readout-plans-confirmed-302634831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XKO.AU","LU1366192091.USD","LU2083900584.USD","TLX.AU","LU1496350171.SGD","EMA","LU1935043023.USD","LU1066051225.USD","LU2456880835.USD","LU0077335932.USD","LU1674673691.USD","LU1935043536.SGD","LU1935042488.USD","LU2237443382.USD","BK7095","BK7129","LU0786609619.USD","LU2237443622.USD","XJO.AU","APC.AU","TLX","LU0314104364.USD","LU0053666078.USD","LU0170899867.USD","BK7142","LU1066053197.SGD","LU1935042991.SGD","BK4141","LU1066051811.HKD","BK4543","LU1778281490.HKD","LU2420271590.USD","LU2237443549.SGD","LU0149725797.USD","BK4139","ASX","ASX.AU","LU2237443978.SGD","LU2236285917.USD","BK7067","RLT.AU","LU1718418525.SGD","BK4526","LU1066051498.USD","XAO.AU","EMA.AU","LU0882574139.USD","APC","CTA","SEC.AU"],"gpt_icon":0},{"id":"2589280669","title":"Eminence Minerals Ltd-Hamersley Iron Ore Project Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2589280669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589280669?lang=en_us&edition=fundamental","pubTime":"2025-12-08 05:26","pubTimestamp":1765142806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251207:nTUE5SR74Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7129","EMA.AU"],"gpt_icon":0},{"id":"2588409781","title":"Cardano price shows early bullish signs but faces heavy resistance walls","url":"https://stock-news.laohu8.com/highlight/detail?id=2588409781","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588409781?lang=en_us&edition=fundamental","pubTime":"2025-12-03 13:39","pubTimestamp":1764740381,"startTime":"0","endTime":"0","summary":"Cardano price stabilizes above key support as RSI recovers, EMAs compress and MACD improves, but stacked ask walls and strong resistance still limit breakout potential.Cardano’s price action entered a stabilization phase on the daily chart following a period of sharp volatility, according to technical analysis from Ecoinimist.com.Cardano, $ADA with the first monthly bullish RSI divergence since March 2020. It may take a little while to play out, but valid as long as we don't see a monthly close below $0.3418.It might be tough to see the month starting off red, but this is a good setup!Cardano’s  price structure remained confined between established support and resistance levels. The token maintained stability above its nearest key support level during recent sell-offs. Multiple resistance zones marked areas of previous selling activity and represented barriers to potential trend reversal.Liquidity data revealed several significant bid and ask walls. On the bid side, the largest defensi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/cardano-price-shows-early-bullish-signs-but-faces-heavy-resistance-walls/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/cardano-price-shows-early-bullish-signs-but-faces-heavy-resistance-walls/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["EMA.AU","ADA.AU","BK4081","BK7016","RSI","BK4150","EMA"],"gpt_icon":0},{"id":"2588092259","title":"XRP price eyes breakout beyond $2.2 as EMAs and MACD turn bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2588092259","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588092259?lang=en_us&edition=fundamental","pubTime":"2025-12-03 13:32","pubTimestamp":1764739929,"startTime":"0","endTime":"0","summary":"XRP price has reclaimed short-term EMAs, with MACD turning higher and RSI improving, but stacked ask walls mean a breakout requires strong volume through resistance.Large Dogecoin transactions fell from 38 to just four, marking a 60-day low in whale activity.XRP price has climbed above short-term trend markers following a consolidation period, according to daily chart analysis, with the cryptocurrency showing signs of renewed buying interest.XRP  faces a resistance band across several price levels, with order-book data showing multiple ask walls representing significant supply barriers. The first major resistance sits at undisclosed levels, followed by larger liquidity barriers at higher price points, market data indicates.On the support side, XRP maintains a price floor at several nearby levels, with multiple bid walls positioned above those supports representing substantial buyer demand, order-book data shows. A breakdown below this support region could shift market sentiment toward ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/xrp-price-eyes-breakout-beyond-2-2-as-emas-and-macd-turn-bullish/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/xrp-price-eyes-breakout-beyond-2-2-as-emas-and-macd-turn-bullish/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["XRP","BK4150","RSI","EMA.AU","BK4081","EMA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}